These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 1907520

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
    Aupetit JF, Loufoua-Moundanga J, Faucon G, Timour Q.
    Br J Pharmacol; 1997 Feb; 120(3):523-9. PubMed ID: 9031759
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prevention by calcium antagonists of profibrillatory effects of class I antiarrhythmic drugs in acute myocardial ischemia: study in pig heart in situ.
    Bui-Xuan B, Aupetit JF, Freysz M, Faucon G, Timour Q.
    Pharmacotherapy; 1997 Feb; 17(4):737-45. PubMed ID: 9250551
    [Abstract] [Full Text] [Related]

  • 7. Disappearance with ischaemic depolarization of the antifibrillatory activity in a sodium channel blocker and appearance in calcium channel blocker.
    Bui-Xuan B, Aupetit JF, Freysz M, Loufoua-Moundanga J, Faucon G, Timour Q.
    Arch Int Pharmacodyn Ther; 1996 Feb; 331(3):246-62. PubMed ID: 9124997
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The clinical use of class IC antiarrhythmic drugs.
    Abi Samra F.
    J La State Med Soc; 1989 May; 141(5):27-31. PubMed ID: 2499646
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L.
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [Abstract] [Full Text] [Related]

  • 12. Characterization of an anesthetized dog model of transient cardiac ischemia and rapid pacing: a pilot study for preclinical assessment of the potential for proarrhythmic risk of novel drug candidates.
    Damiano BP, van der Linde HJ, Van Deuren B, Somers Y, Lubomirski M, Teisman A, Gallacher DJ.
    J Pharmacol Toxicol Methods; 2015 Jun; 72():72-84. PubMed ID: 25450838
    [Abstract] [Full Text] [Related]

  • 13. Frequency- and time-dependent depression of ventricular distal conduction by two novel antiarrhythmic drugs, cibenzoline and flecainide.
    Lang J, Timour Q, Aupetit JF, Lancon JP, Lakhal M, Faucon G.
    Arch Int Pharmacodyn Ther; 1988 Jun; 293():97-108. PubMed ID: 3138954
    [Abstract] [Full Text] [Related]

  • 14. Antiarrhythmic effects of two new propafenone related drugs. A study on four animal models of arrhythmia.
    Wascher TC, Dittrich P, Kukovetz WR.
    Arzneimittelforschung; 1991 Feb; 41(2):119-24. PubMed ID: 2043172
    [Abstract] [Full Text] [Related]

  • 15. [Value of calcium channel blockers in the prevention of ventricular fibrillation of ischemic etiology: experimental arguments].
    Timour Q, Freysz M, Aupetit JF, Loufoua J, Frassati D, Faucon G.
    Bull Acad Natl Med; 1996 Jan; 180(1):215-26; discussion 226-7. PubMed ID: 8696877
    [Abstract] [Full Text] [Related]

  • 16. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Role of asynchronous activation of the ventricular fibres by an ectopic pacemaker in the accidents, especially fibrillation, caused by Ic antiarrhythmic drugs.
    Timour Q, Aupetit JF, Loufoua-Moundanga J, Kioueh I, Omar S, Chevrel G, Faucon G.
    Fundam Clin Pharmacol; 1992 Oct; 6(4-5):159-67. PubMed ID: 1427561
    [Abstract] [Full Text] [Related]

  • 19. A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: the Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial.
    Gulizia M, Mangiameli S, Orazi S, Chiarandà G, Piccione G, Di Giovanni N, Colletti A, Pensabene O, Lisi F, Vasquez L, Grammatico A, Boriani G, PITAGORA Study Investigators.
    Am Heart J; 2008 Jan; 155(1):100-7, 107.e1. PubMed ID: 18082498
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.